Literature DB >> 15974853

Proliferation of fibroblasts cultured from normal gingiva and hereditary gingival fibromatosis is dependent on fatty acid synthase activity.

J P Almeida1, R D Coletta, S D Silva, M Agostini, P A Vargas, L Bozzo, E Graner.   

Abstract

BACKGROUND: Fatty acid synthase (FAS) is the enzyme that synthesizes palmitate from malonyl-CoA and acetyl-CoA. Recent studies have shown that FAS is overexpressed in human cancers and that its activity is necessary for cell proliferation. Hereditary gingival fibromatosis (HGF) is a genetic disease manifested as a progressive enlargement of the gingiva. The pathogenesis of this condition is not understood; however, a proliferative advantage of HGF fibroblasts in comparison with cells from normal gingiva (NG) has been described. The aim of this study was to investigate the role of FAS in NG and HGF fibroblast proliferation.
METHODS: NG and HGF fibroblasts had their proliferative potential assessed by automated cell counting and immunocytochemistry against Ki-67 or proliferating cell nuclear antigen (PCNA). The production of FAS, androgen receptor (AR), and ErbB2 was analyzed by Western blot and the pattern of FAS expression studied by immunocytochemistry. FAS activity was blocked by the specific inhibitor cerulenin.
RESULTS: Higher proliferation rates were found in fibroblasts isolated from HGF than from NG. HGF fibroblasts with greater proliferative potential produced more FAS and AR than the cell lines with lower growth rates, and all studied cell lines produced similar amounts of the ErbB2 protein. In addition, the FAS inhibitor cerulenin was able to significantly reduce the proliferation of both NG and HGF cells.
CONCLUSIONS: These results show that FAS is expressed by gingival fibroblasts and that highly proliferative HGF cells produced more FAS and AR than the other fibroblast cell lines. Moreover, FAS inhibition significantly reduced both NG and HGF fibroblast growth, suggesting a role for the androgen-driven fatty acid biosynthesis in their proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974853     DOI: 10.1902/jop.2005.76.2.272

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  Characterization of fibroblasts with Son of Sevenless-1 mutation.

Authors:  E J Lee; S I Jang; D Pallos; J Kather; T C Hart
Journal:  J Dent Res       Date:  2006-11       Impact factor: 6.116

2.  Extracts from Plastrum testudinis promote proliferation of rat bone-marrow-derived mesenchymal stem cells.

Authors:  D F Chen; H P Zeng; S H Du; H Li; J H Zhou; Y W Li; T T Wang; Z C Hua
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

3.  Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.

Authors:  Débora C Bastos; Jenny Paupert; Catherine Maillard; Fabiana Seguin; Marco A Carvalho; Michelle Agostini; Ricardo D Coletta; Agnès Noël; Edgard Graner
Journal:  Lab Invest       Date:  2016-12-05       Impact factor: 5.662

4.  The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.

Authors:  F Seguin; M A Carvalho; D C Bastos; M Agostini; K G Zecchin; M P Alvarez-Flores; A M Chudzinski-Tavassi; R D Coletta; E Graner
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640

5.  Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.

Authors:  Franco A Rossato; Karina G Zecchin; Paolo G La Guardia; Rose M Ortega; Luciane C Alberici; Rute A P Costa; Rodrigo R Catharino; Edgard Graner; Roger F Castilho; Aníbal E Vercesi
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.